Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc. (CMPX), bought 20,000 shares at $4.05 ($81K) on 2023-01-31, disclosed to the SEC on 2023-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CMPX | BUY | 2023-02-27 | $80K | — | Filing → |
| CMPX | BUY | 2023-02-15 | $77K | — | Filing → |
| CMPX | BUY | 2023-01-24 | $168K | — | Filing → |